Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the post-slider-and-carousel domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/qordata/stg.qordata.com/wp-includes/functions.php on line 6114
False Claims Act – qordata is a Data-Driven Compliance Platform Provider

Category: False Claims Act

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

Gaining physician consent for data disclosure purposes under the EFPIA disclosure code is never easy. However, considering that the acquisition of consent is part of the law under the Directive 95/46/EC on the protection of individuals with regard to the processing of personal data, this is something pharma companies in the EU cannot overlook. With HCP’s […]

The 3rd Annual Global Compliance Congress for Life Sciences was held by the CBI at the Hilton London Olympia on the 16th & 17th of November, 2016. The conference provided an excellent platform for representatives of life sciences companies to network, share ideas and learn from one another. The ambiance at the conference was high-energy […]

For most pharma companies in the EU, seeking the consent of the HCP’s/HCO’s that they indulge in transactions is the most appropriate means of ensuring compliance with data protection laws when disclosing their spending under the EFPIA disclosure code. Indeed, the Code comes with guidance notes that place special emphasis on pharmaceutical companies seeking consent […]

As the reporting date under the US Sunshine Act approaches, compliance teams are working harder than ever to collect spend records and have them audited and ready to submit to CMS. If anything, the frenzy of resolving system issues, vendor management, and personnel challenges makes it extremely hard for most compliance teams to reach the […]

Clinical practices, at least the very best of them, take place out in the open. If anything, these depend on the expertise and input from several groups like academics, clinicians, healthcare organizations, manufacturers of medicines and medical technology, and even patient organizations. These collaborations, however, need to be transparent, and for this particular purpose, the […]

The 17th Annual Pharma and Medical Device Compliance Congress was held at the Mandarin Hotel in Washington, D.C from the 19th to the 21st of October, 2016. The conference provided an excellent opportunity for senior representatives from the compliance, legal, transparency, legal affairs, commercial operations/marketing, and regulatory affairs industries to network and discuss operational best […]